medroxyprogesterone acetate has been researched along with Pituitary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parsons, JA; Winneker, RC | 1 |
| Cookson, KM | 1 |
2 other study(ies) available for medroxyprogesterone acetate and Pituitary Neoplasms
| Article | Year |
|---|---|
Glucocorticoid-like actions of medroxyprogesterone acetate upon MtTW15 rat mammosomatotropic pituitary tumors.
Topics: Animals; Binding, Competitive; Cytosol; Dexamethasone; Estradiol; Female; Glucocorticoids; Growth Hormone; Kinetics; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Experimental; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid | 1981 |
The parenteral toxicity of Cyclofem.
Topics: Adenocarcinoma; Animals; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Injections, Intramuscular; Injections, Intraperitoneal; Injections, Subcutaneous; Macaca mulatta; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred ICR; Pituitary Neoplasms; Rabbits; Rats | 1994 |